For decades, the evolutionary trajectory of the order Chiroptera—the bats—has remained one of biology’s most enduring enigmas. Representing approximately one-fifth…
Read More
The biotech bi-weekly: an expansion into cardiac drug discovery, the world’s largest healthy human protein atlas and large libraries of AI-designed proteins
The global biotechnology sector continues to experience an unprecedented wave of innovation, marked by significant strides in laboratory reagents, cardiovascular…
Read More
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
The landscape of hepatitis C (HCV) management has undergone a profound shift, yet a stark disconnect remains between clinical efficacy…
Read More
EASD 2026: Tirzepatide Outperforms Semaglutide in Real-World Type 2 Diabetes Analysis
The landscape of metabolic disease management continues to undergo a profound transformation as comparative clinical data accumulates for the newest…
Read More
A broken rib from the world’s largest T. rex hid a 66-million-year-old secret
The discovery of "Scotty," the most massive Tyrannosaurus rex skeleton ever unearthed, has long been a centerpiece of paleontological research.…
Read More
The biotech bi-weekly: an expansion into cardiac drug discovery, the world’s largest healthy human protein atlas and large libraries of AI-designed proteins
The global biotechnology sector continues to experience rapid advancements across multiple disciplines, ranging from fundamental laboratory tools to advanced artificial…
Read More
Nature’s Microscopic Speedster: Scientists Unlock the Mechanics of the World’s Fastest Single-Cell Contraction
A tiny aquatic organism, barely visible to the naked eye, is currently rewriting the textbooks on biological motion. The single-celled…
Read More
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
In the global effort to eradicate hepatitis C (HCV), clinical success has frequently collided with the sobering realities of public…
Read More
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
The landscape of hepatitis C (HCV) management has undergone a radical transformation over the last decade, yet the public health…
Read More
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
The landscape of hepatitis C (HCV) management has shifted significantly with the recent regulatory approvals of AbbVie’s direct-acting antiviral therapy,…
Read More
